Human menopausal gonadotropin and recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles

By van Wely M.   Westergaard L.G.   Bossuyt P.M.M.   van der Veen F.  

Fertility and Sterility, Vol. 80, Iss. 5, 2003-11 ,pp. : 1121-1122

Elsevier

Access to resources Recommend Favorite

Evaluation of basal estradiol levels in assisted reproductive technology cycles 2

By Frattarelli J.L.   Bergh P.A.   Drews M.R.   Sharara F.I.   Scott R.T.  

Fertility and Sterility, Vol. 74, Iss. 3, 2000-09 ,pp. : 518-524

Elsevier

Access to resources Recommend Favorite

Predictive value of urine human chorionic gonadotropin after assisted reproductive technology

By Fujiwara H.   Motoyama M.   Shibahara H.   Koike T.   Ogawa S.   Suzuki M.  

Fertility and Sterility, Vol. 80, Iss. 4, 2003-10 ,pp. : 1055-1057

Elsevier

Access to resources Recommend Favorite

Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis

By van Wely M.   Westergaard L.G.   Bossuyt P.M.M.   van der Veen F.  

Fertility and Sterility, Vol. 80, Iss. 5, 2003-11 ,pp. : 1086-1093

Elsevier

Access to resources Recommend Favorite

Recombinant human follicle-stimulating hormone versus urinary-derived human menopausal gonadotropin for controlled ovarian stimulation: the science and art of assisted reproductive technologies

By Kelly E.  

Fertility and Sterility, Vol. 80, Iss. 5, 2003-11 ,pp. : 1105-1107

Elsevier

Access to resources Recommend Favorite